According to the US Centers for Disease Control and Prevention (CDC), of the 4 billion prescriptions filled each year in the United States, half are not taken in accordance with the prescribers’ instructions. QS/1 pharmacy management software offers a label for medication adherence packaging.
QS/1's software is intuitive flexible efficient comprehensive expandable easy to use reliable affordable easy to learn
QS/1's pharmacy management systems are flexible, scalable software solutions
that can fit the needs of any business — big or small.
Enhance your pharmacy's overall productivity with tools to simplify workflow, process claims, manage inventory, and more.
SharpRx packs usability, efficiency and affordability into one easy-to-use system while QS/1 packs productivity and profitability into everything we do for pharmacy.
Provides easy-to-use tools to manage inventory and third party billing for home medical equipment providers (HME).
QS/1 products include many functions and you can customize your software with optional product modules.
QS/1 is partnering with Digital Pharmacist, Inc. to offer secure, HIPAA compliant methods of patient communication through a variety of platforms. This easy to use system will allow patients the convenience of requesting and receiving information from the pharmacy using their personal devices, such as smartphones.
South Carolina DHEC now requires all long-term care (LTC) pharmacies to report dispensed controlled substances to the state's Prescription Monitoring Program (SC PMP). The department wants compliance by the end of the month, and it is in the process of notifying pharmacies.
Over recent decades, obesity has grown into a global health crisis where 38% of U.S. adults and more than 17% of children are currently obese. A 2015 study revealed statistics that are even more alarming: more than 600 million adults and 100 million children worldwide are considered obese.
Effective January 4, 2019, the Michigan Automated Prescription System (MAPS) for the reporting of controlled substances made gabapentin a Schedule V controlled substance. Pharmacies have 7 days to comply, which is Friday, January 11.
2019 Customer Conference
Payment Card Industry Data Security Standard (PCI-DSS)
Payment Application Data Security Standard (PA-DSS)
eRx Network® e-Prescribing
ePAP for ePrescribing Networks
HNAP EHN for clearinghouse health networks